Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.090
-0.050 (-2.34%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Biomerica Balance Sheet
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Equivalents | 1.31 | 2.4 | 4.17 | 9.72 | 5.92 |
Cash & Short-Term Investments | 1.31 | 2.4 | 4.17 | 9.72 | 5.92 |
Cash Growth | -45.48% | -42.47% | -57.09% | 64.26% | 40.90% |
Receivables | 0.79 | 0.73 | 0.95 | 0.72 | 0.77 |
Inventory | 1.71 | 1.49 | 2.38 | 2.06 | 2.42 |
Prepaid Expenses | 0.22 | 0.26 | 0.24 | 0.3 | 0.32 |
Total Current Assets | 4.02 | 4.88 | 7.73 | 12.8 | 9.43 |
Property, Plant & Equipment | 1.95 | 0.56 | 0.94 | 1.25 | 1.52 |
Long-Term Investments | 0.5 | 0.17 | 0.17 | 0.17 | 0.17 |
Other Intangible Assets | 0.21 | 0.23 | 0.21 | 0.17 | 0.17 |
Other Long-Term Assets | 0.08 | 0.11 | 0.2 | 0.08 | 0.1 |
Total Assets | 6.76 | 5.95 | 9.25 | 14.45 | 11.37 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Accounts Payable | 1.17 | 0.3 | 0.56 | 0.34 | 0.74 |
Accrued Expenses | 0.49 | 1.03 | 1.23 | 1.24 | 0.88 |
Short-Term Debt | 0.5 | - | - | - | - |
Current Portion of Leases | 0.24 | 0.36 | 0.33 | 0.3 | 0.34 |
Other Current Liabilities | 0.08 | 0.06 | 0.09 | 0.06 | 0.05 |
Total Current Liabilities | 2.48 | 1.74 | 2.2 | 1.95 | 2.01 |
Long-Term Leases | 1.65 | 0.1 | 0.46 | 0.79 | 1.04 |
Total Liabilities | 4.13 | 1.84 | 2.66 | 2.73 | 3.05 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Common Stock | 0.26 | 0.2 | 0.17 | 1.35 | 1.03 |
Additional Paid-In Capital | 59.43 | 57.18 | 54.72 | 52.71 | 42.45 |
Retained Earnings | -56.94 | -53.17 | -48.2 | -42.22 | -35.08 |
Comprehensive Income & Other | -0.11 | -0.11 | -0.1 | -0.11 | -0.07 |
Total Common Equity | 2.63 | 4.11 | 6.59 | 11.72 | 8.33 |
Shareholders' Equity | 2.63 | 4.11 | 6.59 | 11.72 | 8.33 |
Total Liabilities & Equity | 6.76 | 5.95 | 9.25 | 14.45 | 11.37 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Total Debt | 2.38 | 0.46 | 0.79 | 1.08 | 1.38 |
Net Cash (Debt) | -1.08 | 1.94 | 3.39 | 8.64 | 4.54 |
Net Cash Growth | - | -42.66% | -60.81% | 90.33% | 75.91% |
Net Cash Per Share | -0.37 | 0.84 | 1.61 | 4.88 | 2.86 |
Filing Date Shares Outstanding | 4.59 | 2.82 | 2.1 | 2.1 | 1.67 |
Total Common Shares Outstanding | 3.2 | 2.55 | 2.1 | 2.1 | 1.61 |
Working Capital | 1.54 | 3.14 | 5.53 | 10.85 | 7.42 |
Book Value Per Share | 0.82 | 1.61 | 3.13 | 5.58 | 5.18 |
Tangible Book Value | 2.42 | 3.88 | 6.38 | 11.56 | 8.16 |
Tangible Book Value Per Share | 0.76 | 1.52 | 3.03 | 5.50 | 5.07 |
Machinery | - | 1.6 | 1.6 | 1.54 | 1.52 |
Order Backlog | - | 1.32 | 0.76 | 0.66 | 0.75 |